Details for New Drug Application (NDA): 214726
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 214726
Tradename: | OSELTAMIVIR PHOSPHATE |
Applicant: | Accord Hlthcare |
Ingredient: | oseltamivir phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 214726
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Jul 25, 2022 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
Approval Date: | Jul 25, 2022 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Jul 25, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription